Jubilant Cadista Pharmaceuticals, Inc.: Drug Recall
Recall #D-0767-2022 · 03/08/2022
Class I: Dangerous
Recall Details
- Recall Number
- D-0767-2022
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Jubilant Cadista Pharmaceuticals, Inc.
- Status
- Terminated
- Date Initiated
- 03/08/2022
- Location
- Salisbury, MD, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,174 bottles
Reason for Recall
Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
Product Description
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Distribution Pattern
Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.
Other Recalls by Jubilant Cadista Pharmaceuticals, Inc.
- Class III: Low Risk 12/27/2022
- Class II: Risk 07/18/2022
- Class II: Risk 07/18/2022
- Class III: Low Risk 04/01/2022
- Class III: Low Risk 08/20/2021
View all recalls by Jubilant Cadista Pharmaceuticals, Inc. →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.